ZISHEL FOUNDATION is making the unprecedented approaches to tackle the multi-cancer diagnostics via innovative research on t-cell programming.
ZISHEL LABORATOIRE
28 JUL 2019
ZISHEL LABORATOIRE, France has pursued a collaborations with CHAMeditech on the new PDRN (polydeoxyribonucleotide) induced lipolytic solution. French-made PDRN added onto their patented growth factors.
ZISHEL
GROUP
02 AUG 2019
Last week in Seoul, Our CEO Jimmy Jongwoo Kim along with President Moon was featured on cover page of Korea's one of the fatest growing financial magazines, ECONOMY VIEW.
